Please use this identifier to cite or link to this item:
|Title:||Quantification of aldehyde terminated heparin by SEC-MALLS-UV for the surface functionalization of polycaprolactone biomaterials||Authors:||Irvine, Scott Alexander
Steele, Terry W. J.
Neoh, Koon Gee
Boey, Freddy Yin Chiang
Venkatraman, Subbu S.
|Issue Date:||2015||Source:||Irvine, S. A., Steele, T. W. J., Bhuthalingam, R., Li, M., Boujday, S., Prawirasatya, M., et al. (2015). Quantification of aldehyde terminated heparin by SEC-MALLS-UV for the surface functionalization of polycaprolactone biomaterials. Colloids and Surfaces B: Biointerfaces, 132, 253-263.||Series/Report no.:||Colloids and Surfaces B: Biointerfaces||Abstract:||A straight forward strategy of heparin surface grafting employs a terminal reactive-aldehyde group introduced through nitrous acid depolymerization. An advanced method that allows simultaneously monitoring of both heparin molar mass and monomer/aldehyde ratio by size exclusion chromatography, multi-angle laser light scattering and UV-absorbance (SEC-MALLS–UV) has been developed to improve upon heparin surface grafting. Advancements over older methods allow quantitative characterization by direct (aldehyde absorbance) and indirect (Schiff-based absorbance) evaluation of terminal functional aldehydes. The indirect quantitation of functional aldehydes through labeling with aniline (and the formation of a Schiff-base) allows independent quantitation of both polymer mass and terminal functional groups with the applicable UV mass extinction coefficients determined. The protocol was subsequently used to synthesize an optimized heparin-aldehyde that had minimal polydispersity (PDI < 2) and high reaction yields (yield >60% by mass). The 8 kDa weight averaged molar mass heparin-aldehyde was then grafted on polycaprolactone (PCL), a common implant material. This optimized heparin-aldehyde retained its antithrombin activity, assessed in freshly drawn blood or surface immobilized on PCL films. Anticoagulant activity was equal to or better than the 24 kDa unmodified heparin it was fragmented from.||URI:||https://hdl.handle.net/10356/80595
|ISSN:||0927-7765||DOI:||10.1016/j.colsurfb.2015.05.023||Rights:||© 2015 Elsevier. This is the author created version of a work that has been peer reviewed and accepted for publication by Colloids and Surfaces B: Biointerfaces, Elsevier. It incorporates referee’s comments but changes resulting from the publishing process, such as copyediting, structural formatting, may not be reflected in this document. The published version is available at: [http://dx.doi.org/10.1016/j.colsurfb.2015.05.023].||Fulltext Permission:||open||Fulltext Availability:||With Fulltext|
|Appears in Collections:||MSE Journal Articles|
Files in This Item:
|Quantification of aldehyde terminated heparin by SEC-MALLS-UV for the surface functionalization of polycaprolactone biomaterials.pdf||1.15 MB||Adobe PDF|
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.